NYMOX PHARMACEUTICAL CORP's ticker is and the CUSIP is 67076P952. A total of 1 filers reported holding NYMOX PHARMACEUTICAL CORP in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $35,000 | +1066.7% | 10,200 | +410.0% | 0.00% | – |
| Q2 2015 | $3,000 | +50.0% | 2,000 | -66.7% | 0.00% | – |
| Q4 2014 | $2,000 | -91.3% | 6,000 | +13.2% | 0.00% | – |
| Q3 2014 | $23,000 | +43.8% | 5,300 | +60.6% | 0.00% | – |
| Q2 2014 | $16,000 | -63.6% | 3,300 | -59.3% | 0.00% | -100.0% |
| Q1 2014 | $44,000 | +37.5% | 8,100 | +52.8% | 0.00% | – |
| Q4 2013 | $32,000 | -33.3% | 5,300 | -27.4% | 0.00% | -100.0% |
| Q3 2013 | $48,000 | -14.3% | 7,300 | -33.0% | 0.00% | 0.0% |
| Q2 2013 | $56,000 | – | 10,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GROUP ONE TRADING, L.P. | 7,300 | $48,000 | 0.00% |